CCL19 Antikörper (AA 22-98)
Kurzübersicht für CCL19 Antikörper (AA 22-98) (ABIN2618134)
Target
Alle CCL19 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 22-98
-
Spezifität
- Human CCL19 / MIP3-Beta
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Human recombinant protein fragment corresponding to amino acids 22-98 of human CCL19 (NP_006265) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Approved: WB (1:2000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
-
Andere Bezeichnung
- CCL19 / MIP3-beta
-
Hintergrund
-
Name/Gene ID: CCL19
Subfamily: Intercrine beta
Family: Intercrine
Synonyms: CCL19, C-C motif chemokine 19, CKb11, CC chemokine ligand 19, EBI1 ligand chemokine, EBI1-ligand chemokine, Exodus-3, ELC, MIP-3-beta, MIP3B, SCYA19, Small-inducible cytokine A19, Beta chemokine exodus-3, Beta-chemokine exodus-3, CK beta-11, MIP-3b -
Gen-ID
- 6363
-
NCBI Accession
- NP_006265
-
Pathways
- Positive Regulation of Immune Effector Process
Target
-